Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-29
DOI
10.3389/fphar.2019.00853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL Clinical Practice Guidelines: Drug-induced liver injury
- (2019) Raúl Andrade et al. JOURNAL OF HEPATOLOGY
- Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
- (2019) Tao Shen et al. GASTROENTEROLOGY
- Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
- (2019) Rolf Teschke Frontiers in Pharmacology
- Drug induced liver injury with analysis of alternative causes as confounding variables
- (2018) Rolf Teschke et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
- (2018) Gaby Danan et al. DRUG SAFETY
- Expanding our toolkit to better identify drug-induced liver injury in electronic medical records
- (2018) Christine M. Hunt LIVER INTERNATIONAL
- The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
- (2018) Ammar Hassan et al. LIVER INTERNATIONAL
- Drug-induced liver injury: a safety review
- (2018) Miren García-Cortés et al. Expert Opinion On Drug Safety
- Drug-Induced Liver Injury: Highlights of the Recent Literature
- (2018) Mark Real et al. DRUG SAFETY
- Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan
- (2018) Mitsuhiko Aiso et al. HEPATOLOGY RESEARCH
- The diagnostic role of miR-122 in drug-induced liver injury
- (2018) Yiqi Liu et al. MEDICINE
- Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?
- (2017) Omar Shahbaz et al. Expert Opinion on Drug Metabolism & Toxicology
- Drug-induced liver injury: recent advances in diagnosis and risk assessment
- (2017) Gerd A Kullak-Ublick et al. GUT
- CSH guidelines for the diagnosis and treatment of drug-induced liver injury
- (2017) Yue-cheng Yu et al. Hepatology International
- Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
- (2017) Rolf Teschke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases
- (2017) Eng Hooi Tan et al. LIVER INTERNATIONAL
- The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study
- (2016) Abhasnee Sobhonslidsuk et al. BMC GASTROENTEROLOGY
- Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature
- (2016) Philip Sarges et al. DRUG SAFETY
- Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease
- (2016) Rolf Teschke et al. DRUG SAFETY
- “Drug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge”
- (2016) Raúl J. Andrade et al. Expert Opinion on Drug Metabolism & Toxicology
- Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients
- (2016) Yun Zhu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period
- (2016) Mille Baekdal et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study
- (2015) Antonios Douros et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- How to Diagnose and Exclude Drug-Induced Liver Injury
- (2015) Paul B. Watkins DIGESTIVE DISEASES
- A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury
- (2015) Lauren Heidemann et al. DIGESTIVE DISEASES AND SCIENCES
- Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports
- (2015) Einar S. Björnsson et al. HEPATOLOGY
- RUCAM in Drug and Herb Induced Liver Injury: The Update
- (2015) Gaby Danan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps
- (2015) Rolf Teschke et al. Frontiers in Pharmacology
- Causality Assessment for Suspected DILI During Clinical Phases of Drug Development
- (2014) Arie Regev et al. DRUG SAFETY
- Rivaroxaban postmarketing risk of liver injury
- (2014) Stefan Russmann et al. JOURNAL OF HEPATOLOGY
- Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN)
- (2014) Paul H. Hayashi et al. LIVER INTERNATIONAL
- A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method
- (2014) Tadaaki Hanatani et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Epidemiology and Risk Factors for Idiosyncratic Drug-Induced Liver Injury
- (2014) Einar Björnsson SEMINARS IN LIVER DISEASE
- An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data
- (2013) T. Craig Cheetham et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data
- (2012) Janet Shin et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started